Lumos Pharma (LUMO) Earnings Date, Estimates & Call Transcripts → America’s worst nightmare? (From Porter & Company) (Ad) Free LUMO Stock Alerts $2.86 -0.04 (-1.38%) (As of 05/13/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 15Before Market OpensConfirmedActual EPS (Mar. 7) -$1.17 Beat By $0.01 Consensus EPS (Mar. 7) -$1.18 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Lumos Pharma Earnings AlertsEnter your email address below to receive the latest news and earnings results for LUMO and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueLUMO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LUMO Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. Lumos Pharma Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($2.80) EPSNext Year EPS Consensus Estimate: ($2.00) EPSLUMO Earnings Date and InformationLumos Pharma last issued its earnings results on March 7th, 2024. The reported ($1.17) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.18) by $0.01. The company earned $0.83 million during the quarter, compared to analysts' expectations of $0.01 million. Lumos Pharma has generated ($4.19) earnings per share over the last year (($4.19) diluted earnings per share). Earnings for Lumos Pharma are expected to grow in the coming year, from ($2.80) to ($2.00) per share. Lumos Pharma has confirmed that its next quarterly earnings report will be published on Wednesday, May 15th, 2024. Lumos Pharma will be holding an earnings conference call on Wednesday, May 15th at 8:30 AM Eastern. Interested parties can register for or listen to the call.. Read More Lumos Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/15/2024Confirmed)------- 3/7/2024Q4 2023($1.18)($1.17)+$0.01($1.17)$0.01 million$0.83 million 11/7/2023Q3 2023($1.10)($1.04)+$0.06($1.04)$0.19 million$0.01 million8/9/2023Q2 2023($1.06)($1.09)($0.03)($1.09)$0.50 million$0.53 million5/3/2023Q1 2023($1.12)($0.89)+$0.23($0.89)$0.31 million$0.69 million3/1/2023Q4 2022($0.95)($0.98)($0.03)($0.98)$0.34 million$0.51 million11/14/2022Q3 2022($1.01)($0.86)+$0.15($0.86)$0.40 million$0.50 million Get the Latest News and Ratings for LUMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lumos Pharma and its competitors with MarketBeat's FREE daily newsletter. 8/9/2022Q2 2022($0.98)($0.94)+$0.04($0.94)$0.11 million$0.40 million5/10/2022Q1 2022($0.92)($0.92)-($0.92)-$0.11 million3/10/2022Q4 2021($0.92)($0.68)+$0.24($0.68)-$0.22 million11/3/2021Q3 2021($1.06)($0.90)+$0.16($0.90)--8/5/2021Q2 2021($1.01)($1.04)($0.03)($1.04)-$0.01 million Lumos Pharma Earnings - Frequently Asked Questions When is Lumos Pharma's earnings date? Lumos Pharma has confirmed that its next quarterly earnings data will be published on Wednesday, May 15th, 2024. Learn more on LUMO's earnings history. Did Lumos Pharma beat their earnings estimates last quarter? In the previous quarter, Lumos Pharma (NASDAQ:LUMO) reported ($1.17) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.18) by $0.01. Learn more on analysts' earnings estimate vs. LUMO's actual earnings. How can I listen to Lumos Pharma's earnings conference call? The conference call for Lumos Pharma's latest earnings report can be listened to online. Listen to Conference Call How can I read Lumos Pharma's conference call transcript? The conference call transcript for Lumos Pharma's latest earnings report can be read online. Read Transcript How can I view Lumos Pharma's earnings report? Lumos Pharma's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Lumos Pharma generate each year? Lumos Pharma (NASDAQ:LUMO) has a recorded annual revenue of $2.05 million. How much profit does Lumos Pharma generate each year? Lumos Pharma (NASDAQ:LUMO) has a recorded net income of -$34.03 million. LUMO has generated -$4.19 earnings per share over the last four quarters. What is Lumos Pharma's EPS forecast for next year? Lumos Pharma's earnings are expected to grow from ($2.80) per share to ($2.00) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Oncternal Therapeutics Earnings Results Iterum Therapeutics Earnings Results Forte Biosciences Earnings Results Lisata Therapeutics Earnings Results TherapeuticsMD Earnings Results Bullfrog AI Earnings Results Biora Therapeutics Earnings Results Cumberland Pharmaceuticals Earnings Results Lipocine Earnings Results RenovoRx Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:LUMO) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyElon’s New Device is About to Shock the WorldInvestorPlaceConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe only AI company you should be looking atBehind the MarketsCharles Payne Demystifies OptionsUnstoppable ProsperityForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lumos Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
